| Year |
Citation |
Score |
| 2018 |
Connolly B, Isaacs C, Cheng L, Asrani KH, Subramanian RR. SERPINA1 mRNA as a Treatment for Alpha-1 Antitrypsin Deficiency. Journal of Nucleic Acids. 2018: 8247935. PMID 30009048 DOI: 10.1155/2018/8247935 |
0.336 |
|
| 2018 |
Asrani KH, Cheng L, Cheng CJ, Subramanian RR. Arginase I mRNA therapy - A novel approach to rescue arginase 1 enzyme deficiency. Rna Biology. PMID 29923457 DOI: 10.1080/15476286.2018.1475178 |
0.329 |
|
| 2018 |
Asrani KH, Farelli JD, Stahley MR, Miller RL, Cheng CJ, Subramanian RR, Brown JM. Optimization of mRNA untranslated regions for improved expression of therapeutic mRNA. Rna Biology. 1-7. PMID 29578372 DOI: 10.1080/15476286.2018.1450054 |
0.364 |
|
| 2018 |
Farelli JD, Asrani KH, Isaacs C, deBear JS, Stahley MR, Shah A, Lasaro MA, Cheng CJ, Subramanian RR. Leveraging Rational Protein Engineering to Improve mRNA Therapeutics. Nucleic Acid Therapeutics. PMID 29437538 DOI: 10.1089/Nat.2017.0697 |
0.366 |
|
| 2012 |
Subramanian RR, Yamakawa A. Combination therapy targeting Raf-1 and MEK causes apoptosis of HCT116 colon cancer cells. International Journal of Oncology. 41: 1855-62. PMID 22922669 DOI: 10.3892/Ijo.2012.1602 |
0.379 |
|
| 2011 |
Moschos SA, Frick M, Taylor B, Turnpenny P, Graves H, Spink KG, Brady K, Lamb D, Collins D, Rockel TD, Weber M, Lazari O, Perez-Tosar L, Fancy SA, Lapthorn C, ... ... Subramanian R, et al. Uptake, efficacy, and systemic distribution of naked, inhaled short interfering RNA (siRNA) and locked nucleic acid (LNA) antisense. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 2163-8. PMID 21971426 DOI: 10.1038/Mt.2011.206 |
0.305 |
|
| 2009 |
Titus MA, Tan JA, Gregory CW, Ford OH, Subramanian RR, Fu H, Wilson EM, Mohler JL, French FS. 14-3-3{eta} Amplifies Androgen Receptor Actions in Prostate Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 7571-7581. PMID 19996220 DOI: 10.1158/1078-0432.Ccr-08-1976 |
0.467 |
|
| 2004 |
Subramanian RR, Zhang H, Wang H, Ichijo H, Miyashita T, Fu H. Interaction of apoptosis signal-regulating kinase 1 with isoforms of 14-3-3 proteins. Experimental Cell Research. 294: 581-91. PMID 15023544 DOI: 10.1016/J.Yexcr.2003.12.009 |
0.675 |
|
| 2004 |
Titus MA, Gregory CW, Smitherman AB, Subramanian RR, Fu H, Mohler JL, French FS. 582: 14-3-3η Protein Mediates AR Transactivation in Recurrent Prostate Cancer The Journal of Urology. 171: 154-155. DOI: 10.1016/S0022-5347(18)37844-3 |
0.497 |
|
| 2003 |
Zhao JJ, Gjoerup OV, Subramanian RR, Cheng Y, Chen W, Roberts TM, Hahn WC. Human mammary epithelial cell transformation through the activation of phosphatidylinositol 3-kinase. Cancer Cell. 3: 483-95. PMID 12781366 DOI: 10.1016/S1535-6108(03)00088-6 |
0.324 |
|
| 2002 |
Masters SC, Subramanian RR, Truong A, Yang H, Fujii K, Zhang H, Fu H. Survival-promoting functions of 14-3-3 proteins. Biochemical Society Transactions. 30: 360-5. PMID 12196095 DOI: 10.1042/Bst0300360 |
0.736 |
|
| 2002 |
Furman C, Short SM, Subramanian RR, Zetter BR, Roberts TM. DEF-1/ASAP1 is a GTPase-activating protein (GAP) for ARF1 that enhances cell motility through a GAP-dependent mechanism. The Journal of Biological Chemistry. 277: 7962-9. PMID 11773070 DOI: 10.1074/Jbc.M109149200 |
0.464 |
|
| 2002 |
Masters SC, Subramanian RR, Truong A, Yang H, Fujii K, Zhang H, Fu H. Prosurvival Function of 14-3-3 Proteins Biochemical Society Transactions. 30: A62-A62. DOI: 10.1042/Bst030A062A |
0.709 |
|
| 2001 |
Subramanian RR, Masters SC, Zhang H, Fu H. Functional conservation of 14-3-3 isoforms in inhibiting bad-induced apoptosis. Experimental Cell Research. 271: 142-51. PMID 11697890 DOI: 10.1006/Excr.2001.5376 |
0.744 |
|
| 2001 |
Chiang CW, Harris G, Ellig C, Masters SC, Subramanian R, Shenolikar S, Wadzinski BE, Yang E. Protein phosphatase 2A activates the proapoptotic function of BAD in interleukin- 3-dependent lymphoid cells by a mechanism requiring 14-3-3 dissociation. Blood. 97: 1289-97. PMID 11222372 DOI: 10.1182/Blood.V97.5.1289 |
0.707 |
|
| 2000 |
Fu H, Subramanian RR, Masters SC. 14-3-3 proteins: structure, function, and regulation. Annual Review of Pharmacology and Toxicology. 40: 617-47. PMID 10836149 DOI: 10.1146/Annurev.Pharmtox.40.1.617 |
0.743 |
|
| 1998 |
Subramanian RR, Yang H, Wjicox JN, Masters SC, Fu H. Isoform specificity of 14-3-3 proteins Faseb Journal. 12. |
0.713 |
|
| 1994 |
Wilcox JN, Rodriguez J, Subramanian R, Ollerenshaw J, Zhong C, Hayzer DJ, Horaist C, Hanson SR, Lumsden A, Salam TA, Kelly AB, Harker LA, Runge M. Characterization of thrombin receptor expression during vascular lesion formation Circulation Research. 75: 1029-1038. PMID 7955141 DOI: 10.1161/01.Res.75.6.1029 |
0.329 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 1997 |
Wilcox JN, Subramanian RR, Sundell CL, Ross Tracey W, Pollock JS, Harrison DG, Marsden PA. Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels Arteriosclerosis, Thrombosis, and Vascular Biology. 17: 2479-2488. PMID 9409218 DOI: 10.1161/01.Atv.17.11.2479 |
0.298 |
|
| 2015 |
Subramanian RR, Wysk MA, Ogilvie KM, Bhat A, Kuang B, Rockel TD, Weber M, Uhlmann E, Krieg AM. Enhancing antisense efficacy with multimers and multi-targeting oligonucleotides (MTOs) using cleavable linkers. Nucleic Acids Research. PMID 26446989 DOI: 10.1093/Nar/Gkv992 |
0.297 |
|
| 2018 |
Liu-Chen S, Connolly B, Cheng L, Subramanian RR, Han Z. mRNA treatment produces sustained expression of enzymatically active human ADAMTS13 in mice. Scientific Reports. 8: 7859. PMID 29777164 DOI: 10.1038/S41598-018-26298-4 |
0.295 |
|
| 2011 |
Knowlton DL, Tang K, Henstock PV, Subramanian RR. miRNA Alterations Modify Kinase Activation In The IGF-1 Pathway And Correlate With Colorectal Cancer Stage And Progression In Patients. Journal of Cancer. 2: 490-502. PMID 21980324 DOI: 10.7150/Jca.2.490 |
0.284 |
|
| 2019 |
Kukreja A, Lasaro M, Cobaugh C, Forbes C, Tang JP, Gao X, Martin-Higueras C, Pey AL, Salido E, Sobolov S, Subramanian RR. Systemic Alanine Glyoxylate Aminotransferase Messenger RNA Improves Glyoxylate Metabolism in a Mouse Model of Primary Hyperoxaluria Type 1. Nucleic Acid Therapeutics. PMID 30676254 DOI: 10.1089/Nat.2018.0740 |
0.275 |
|
| 2011 |
Caffrey DR, Zhao J, Song Z, Schaffer ME, Haney SA, Subramanian RR, Seymour AB, Hughes JD. siRNA off-target effects can be reduced at concentrations that match their individual potency. Plos One. 6: e21503. PMID 21750714 DOI: 10.1371/Journal.Pone.0021503 |
0.269 |
|
| 2018 |
Roseman DS, Khan T, Rajas F, Jun LS, Asrani KH, Isaacs C, Farelli JD, Subramanian RR. G6PC mRNA Therapy Positively Regulates Fasting Blood Glucose and Decreases Liver Abnormalities in a Mouse Model of Glycogen Storage Disease 1a. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 29428299 DOI: 10.1016/J.Ymthe.2018.01.006 |
0.248 |
|
| 2011 |
Wang Y, Song Z, Wagner JD, Pachuk C, Subramanian RR. Development of a sensitive ELISA to quantify apolipoprotein CIII in nonhuman primate serum. Journal of Lipid Research. 52: 1265-71. PMID 21371998 DOI: 10.1194/Jlr.D011148 |
0.22 |
|
| 2022 |
Desjardins CA, Yao M, Hall J, O'Donnell E, Venkatesan R, Spring S, Wen A, Hsia N, Shen P, Russo R, Lan B, Picariello T, Tang K, Weeden T, Zanotti S, ... Subramanian R, et al. Enhanced exon skipping and prolonged dystrophin restoration achieved by TfR1-targeted delivery of antisense oligonucleotide using FORCE conjugation in mdx mice. Nucleic Acids Research. PMID 35944903 DOI: 10.1093/nar/gkac641 |
0.199 |
|
| 1995 |
Ohara Y, Peterson TE, Sayegh HS, Subramanian RR, Wilcox JN, Harrison DG. Dietary correction of hypercholesterolemia in the rabbit normalizes endothelial superoxide anion production Circulation. 92: 898-903. PMID 7641372 DOI: 10.1161/01.Cir.92.4.898 |
0.196 |
|
| 2016 |
Liu D, Xiao Y, Subramanian RR, Okamoto EI, Wilcox JN, Anderson L, De Leon H. Potential Role of Axonal Chemorepellent Slit2 in Modulating Adventitial Inflammation in a Rat Carotid Artery Balloon Injury Model. Journal of Cardiovascular Pharmacology. PMID 26841069 DOI: 10.1097/FJC.0000000000000369 |
0.17 |
|
| 1981 |
Subramanian RR. Confusion in nuclear strategy Strategic Analysis. 5: 424-427. DOI: 10.1080/09700168109425831 |
0.065 |
|
| 1981 |
Subramanian RR. Australia in targetting infra-structure Strategic Analysis. 5: 111-114. DOI: 10.1080/09700168109427538 |
0.063 |
|
| 1982 |
Subramanian RR. Controlled nuclear war: EMP factor Strategic Analysis. 5: 565-568. DOI: 10.1080/09700168209425853 |
0.058 |
|
| 2009 |
Wymore RA, Subramanian RR, Sorenson KS, Evans PJ, Bamer J, Tulsiani U. Pilot-scale bioremediation with recirculation for a TCE source area with high 1,1-DCE concentrations In Situ and On-Site Bioremediation-2009: Proceedings of the 10th International in Situ and On-Site Bioremediation Symposium. |
0.058 |
|
| 1974 |
Kumar N, Subramanian RR. A probabilistic approach to the problem of electron localization in disordered systems and sharpness of the mobility edge Journal of Physics C: Solid State Physics. 7: 1817-1821. DOI: 10.1088/0022-3719/7/10/008 |
0.055 |
|
| 1983 |
Subramanian RR. Reagan's nuclear strategy for the year 2000 Strategic Analysis. 7: 58-61. DOI: 10.1080/09700168309426989 |
0.053 |
|
| 1980 |
Subramanian RR. The central strategic balance in the 1980s Strategic Analysis. 4: 232-237. DOI: 10.1080/09700168009421615 |
0.052 |
|
| 1979 |
Subramanian RR. Is Argentina going nuclear? Strategic Analysis. 2: 462-463. DOI: 10.1080/09700167909425767 |
0.05 |
|
| 2015 |
Subramanian RR. India’s nuclear situation: Where to? Strategic Analysis. 39: 610-623. DOI: 10.1080/09700161.2015.1070472 |
0.049 |
|
| 1982 |
Subramanian RR. Third generation nuclear weapons Strategic Analysis. 6: 567-569. DOI: 10.1080/09700168209425919 |
0.049 |
|
| 1983 |
Subramanian RR. US non-proliferation policy and Pakistan Strategic Analysis. 6: 699-703. DOI: 10.1080/09700168309426970 |
0.049 |
|
| 1980 |
Subramanian RR. Pakistan's nuclear hijack: Implications if true Strategic Analysis. 3: 349-351. DOI: 10.1080/09700168009421557 |
0.048 |
|
| 1982 |
Subramanian RR. Israel, South Africa and Taiwan—A nuclear axis? Strategic Analysis. 6: 261-263. DOI: 10.1080/09700168209425863 |
0.043 |
|
| 1979 |
Subramanian RR. Pakistan's nuclear option: Open or closed? Strategic Analysis. 3: 286-288. DOI: 10.1080/09700167909421540 |
0.038 |
|
| 1978 |
Subramanian RR. SALT and the MX missile Strategic Analysis. 2: 273-275. DOI: 10.1080/09700167809421478 |
0.038 |
|
| 1983 |
Subramanian RR. The nuclear dimension Strategic Analysis. 7: 98-108. DOI: 10.1080/09700168309431859 |
0.037 |
|
| 1982 |
Subramanian RR. Nuclear test ban: How feasible? Strategic Analysis. 6: 498-502. DOI: 10.1080/09700168209425908 |
0.037 |
|
| 1979 |
Subramanian RR. The IAEA general conference: A new perspective? Strategic Analysis. 3: 342-344. DOI: 10.1080/09700167909421554 |
0.026 |
|
| 1983 |
Subramanian RR. Nuclear missiles in Europe: Beyond Andropov's proposals Strategic Analysis. 6: 684-687. DOI: 10.1080/09700168309425941 |
0.026 |
|
| 1979 |
Subramanian RR. India and China: US nuclear discrimination? Strategic Analysis. 2: 353-356. DOI: 10.1080/09700167909425744 |
0.025 |
|
| 1982 |
Subramanian RR. India's nuclear policy Strategic Analysis. 6: 401-407. DOI: 10.1080/09700168209425891 |
0.022 |
|
| 2010 |
Subramanian RR. The politics of nuclear energy Strategic Analysis. 34: 811-816. DOI: 10.1080/09700161.2010.512474 |
0.022 |
|
| 1980 |
Subramanian RR. India's nuclear policy: Time for change? Strategic Analysis. 3: 435-437. DOI: 10.1080/09700168009423337 |
0.02 |
|
| 1982 |
Subramanian RR. Pentagon plan for protracted nuclear war Strategic Analysis. 6: 376-380. DOI: 10.1080/09700168209425886 |
0.016 |
|
| 1979 |
Subramanian RR. The Re-Emergence of chemical weapons in modern warfare Strategic Analysis. 3: 35-37. DOI: 10.1080/09700167909425401 |
0.013 |
|
| 1980 |
Subramanian RR. Nuclearisation of Indo-Pak sub-continent after Afghanistan? Strategic Analysis. 3: 398-401. DOI: 10.1080/09700168009425405 |
0.012 |
|
| 2016 |
Jamari SKM, Kasi R, Ismail L, Nor NAM, Subramanian RR, Ramesh Subramaniam T, Balakrishnan V, Arof AKM. Studies on anticorrosion properties of polyaniline-TiO2 blended with acrylic-silicone coating using electrochemical impedance spectroscopy Pigment and Resin Technology. 45: 18-23. DOI: 10.1108/PRT-02-2014-0016 |
0.012 |
|
| 2010 |
Manecius Selvakumar J, Subramanian RR, Sathianarayanan AN, Harikrishnan D, Jayakumar G, Muthukumaran VK, Murugesan D, Chandresekaran M, Elangovan E, Prakash D, Vadivelan V, Radhakrishnan A, Ramesh M, Ramadass S, Atmanand GA, et al. Technology tool for deep ocean exploration-Remotely Operated Vehicle Proceedings of the International Offshore and Polar Engineering Conference. 1: 206-212. |
0.01 |
|
| 1983 |
Subramanian RR. Andropov's proposals on euromissiles Strategic Analysis. 6: 644-646. DOI: 10.1080/09700168309425932 |
0.01 |
|
| 1982 |
Subramanian RR. US and soviet strategic relations: From SALT to START Strategic Analysis. 6: 213-219. DOI: 10.1080/09700168209427598 |
0.01 |
|
| 1982 |
Subramanian RR. Chemical weapons: Another US-Soviet arms race? Strategic Analysis. 5: 702-704. DOI: 10.1080/09700168209427577 |
0.01 |
|
| 1980 |
Subramanian RR. Pakistan's route to the Bomb: Uranium or Plutonium? Strategic Analysis. 4: 318-321. DOI: 10.1080/09700168009431854 |
0.01 |
|
| 1979 |
Subramanian RR. Military potential of India's space programme Strategic Analysis. 2: 387-389. DOI: 10.1080/09700167909425752 |
0.01 |
|
| 1978 |
Subramanian RR. New French enrichment technology for India Strategic Analysis. 2: 304-306. DOI: 10.1080/09700167809423333 |
0.01 |
|
| Hide low-probability matches. |